These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6469506)

  • 1. Chemical characterization of ASTA Z 7557 (INN mafosfamide, CIS-4-sulfoethylthio-cyclophosphamide), a stable derivative of 4-hydroxy-cyclophosphamide.
    Niemeyer U; Engel J; Scheffler G; Molge K; Sauerbier D; Weigert W
    Invest New Drugs; 1984; 2(2):133-9. PubMed ID: 6469506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation mechanisms of mafosfamide and the role of thiols in cyclophosphamide metabolism.
    Kwon CH; Borch RF; Engel J; Niemeyer U
    J Med Chem; 1987 Feb; 30(2):395-9. PubMed ID: 3806619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
    Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL
    J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative activity of 2-[N, N-bis-(2-chloroethyl)-amino]-4-[2-sulfonato-ethylthio]-tetrah ydr o-2H-1 , 3,2-oxazaphosphorine-2-oxide cyclohexamine (ASTA Z 7557, INN mafosfamide) against human and murine tumor cells in vitro.
    Kovach JS; Svingen PA
    Invest New Drugs; 1984; 2(2):155-9. PubMed ID: 6469509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide).
    Alberts DS; Einspahr JG; Struck R; Bignami G; Young L; Surwit EA; Salmon SE
    Invest New Drugs; 1984; 2(2):141-8. PubMed ID: 6469507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The key role of hydroxylation for the cytostatic activity and selectivity of cyclophosphamide.
    Hilgard P; Brock N
    Invest New Drugs; 1984; 2(2):131-2. PubMed ID: 6469505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and toxicity of 4-(2-sulfonatoethylthio)-cyclophosphamide cyclohexylamine salt (ASTA Z 7557, INN mafosfamide) after intraperitoneal administration to mice.
    Roberts JD; Hacker MP; Newman RA; McCormack JJ; Krakoff IH
    Invest New Drugs; 1984; 2(2):215-20. PubMed ID: 6469517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase-I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345 842) and limited phase-I data on mafosfamide-lysine.
    Bruntsch U; Groos G; Hiller TA; Wandt H; Tigges FJ; Gallmeier WM
    Invest New Drugs; 1985; 3(3):293-6. PubMed ID: 4066222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluoro- and 5-chlorocyclophosphamide: synthesis, metabolism, and antitumor activity of the cis and trans isomers.
    Foster AB; Jarman M; Kinas RW; van Maanen JM; Taylor GN; Gaston JL; Parkin A; Richardson AC
    J Med Chem; 1981 Dec; 24(12):1399-403. PubMed ID: 7310816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.
    Hohorst HJ; Draeger U; Peter G; Voelcker G
    Cancer Treat Rep; 1976 Apr; 60(4):309-15. PubMed ID: 1277206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution.
    Borch RF; Hoye TR; Swanson TA
    J Med Chem; 1984 Apr; 27(4):490-4. PubMed ID: 6708051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of activation of 4-hydroxycyclophosphamide.
    Borch RF; Millard JA
    J Med Chem; 1987 Feb; 30(2):427-31. PubMed ID: 3806624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental toxicology of ASTA Z 7557 (INN mafosfamide).
    Pohl J; Hilgard P; Jahn W; Zechel HJ
    Invest New Drugs; 1984; 2(2):201-6. PubMed ID: 6469515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. 2. Direct observation, characterization, and reactivity studies of iminocyclophosphamide and related species.
    Boyd VL; Summers MF; Ludeman SM; Egan W; Zon G; Regan JB
    J Med Chem; 1987 Feb; 30(2):366-74. PubMed ID: 3806617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectroscopic detection of iminocyclophosphamide and its possible role in cyclophosphamide metabolism.
    Kwon CH; Kirk MC; Struck RF; Borch RF
    J Med Chem; 1987 Jun; 30(6):1110-4. PubMed ID: 3585908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Base-catalyzed hydrolysis of 4-hydroperoxycyclophosphamide: evidence for iminocyclophosphamide as an intermediate.
    Borch RF; Getman KM
    J Med Chem; 1984 Apr; 27(4):485-90. PubMed ID: 6708050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and biological evaluation of hydrolysis products of cyclophosphamide.
    Gilard V; Martino R; Malet-Martino MC; Kutscher B; Müller A; Niemeyer U; Pohl J; Polymeropoulos EE
    J Med Chem; 1994 Nov; 37(23):3986-93. PubMed ID: 7966159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activity of cyclophosphamide analogues. 3. Preparation, molecular structure determination and anticancer screening of racemic cis- and trans-4-phenylcyclophosphamide.
    Boyd VL; Zon G; Himes VL; Stalick JK; Mighell AD; Secor HV
    J Med Chem; 1980 Apr; 23(4):372-5. PubMed ID: 7381836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human B lymphocyte differentiation by a stable metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide).
    Gorski A; Korczak-Kowalska G
    Invest New Drugs; 1984; 2(2):227-9. PubMed ID: 6236164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ASTA Z 7557 (INN mafosfamide) a precursor of 4-hydroxy-cyclophosphamide on human T-lymphocytes' Fc-receptors and immunoregulatory functions.
    Saal JG; Hadam M; Frank F; Rautenstrauch H; Fritz P
    Invest New Drugs; 1984; 2(2):231-5. PubMed ID: 6236165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.